What is the Impact Factor of Cannabis and Cannabinoid Research?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Cannabis and Cannabinoid Research is 2.50, ranking in quartile Q3 of Web of Science (SCIE).

Is Cannabis and Cannabinoid Research indexed in Web of Science or Scopus?

Yes, Cannabis and Cannabinoid Research is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.027 (Q1) and an H-index of 52.

Who publishes Cannabis and Cannabinoid Research and what is the Article Processing Charge (APC)?

Cannabis and Cannabinoid Research is published by MARY ANN LIEBERT, INC. The estimated Article Processing Charge (APC) is approximately $3,279 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Cannabis and Cannabinoid Research?

The official ISO-4 abbreviation of Cannabis and Cannabinoid Research is "CANNABIS CANNABINOID RES". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q1SCImago #4,683Hybrid

Cannabis and Cannabinoid Research

Abbreviation (ISO):CANNABIS CANNABINOID RES

•

Identifier (ISSN):2578-5125(Print)/2378-8763(Online)

•

Publisher:MARY ANN LIEBERT, INC

Official Website Submission Portal Compare

Clarivate IF (2026)

2.5↓ -0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2022–2026)

Clarivate IF trend for Cannabis and Cannabinoid Research

WoS Q3

Annual Impact Factor Metric

Current (2026):2.5

Scopus SJR & RankScopus Q1

1.027

#4,683

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

52 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate9.7%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

98articles/year

9.17% Gold OA•92.37% Original Research

Aims & Scope

Cannabis and Cannabinoid Research (abbr: CANNABIS CANNABINOID RES, ISSN: 2578-5125) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by MARY ANN LIEBERT, INC in United States. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 1.027 (Q1), an H-index of 52.

Topics Covered (Recognized by AI)

Medicine98.6%Psychology86.4%Biology85.5%Psychiatry79%Internal medicine74.9%Psychotherapist70.7%Cannabis69.8%Chemistry62.2%Biochemistry59.4%Genetics56.5%Receptor46.5%Pharmacology39.4%Pathology37.3%Cannabidiol35.5%Cannabinoid32.3%Neuroscience29%Endocrinology24.2%Mathematics21%

Primary Research Areas

Pharmacology & Pharmacy

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank205/356

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank168/356

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	205/356	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	168/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.5

Articles / Year24

Total Citations2

2025

IF2.7

Articles / Year57

Total Citations67

2024

IF3.1

Articles / Year93

Total Citations372

2023

IF3.8

Articles / Year116

Total Citations897

2022

IF4.786

Articles / Year142

Total Citations1,551

Year	Impact Factor	Articles / Year	Total Citations
2026	2.5	24	2
2025	2.7	57	67
2024	3.1	93	372
2023	3.8	116	897
2022	4.786	142	1,551
2021	—	94	1,982
2020	—	74	1,984
2019	—	49	1,594
2018	—	31	2,103
2017	—	33	2,787
2016	—	37	2,927
2011	—	1	0

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,683Scopus Q1SCImago Profile

Scopus Coverage:2016-2025

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.027

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.16

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,279 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,300

3-Year Documents369

Citable Documents350

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate46.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Complementary and Alternative MedicineQ1

PharmacologyQ1

Pharmacology (medical)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 9.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

The journal enforces rigorous peer evaluation with an annual output of approximately 98 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,279 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.